Due to the popularity of CBD , Dogs and cats are increasingly taking the non-THC cannabis compound as their owners seek to provide much needed relief to their four-legged friends for symptoms of everything from anxiety to pain and epileptic seizures. While there’s large amounts of data proving CBD oil for dogs works for many of these ailments, some people are swearing by it and more vets in america are prescribing it.

“I don’t think people should think of this as a panacea and start giving CBD to their pets for every ailment,” said Dr. Francisco DiPolo, a veterinarian at Worth Street Veterinary Center in New York City, who prescribes it for some of his patients. “I think it’s powerful and we need to learn more about it.”

Over the past several years, medical marijuana and CBD oil use has become a controversial topic not only within the medical community but also at state and national legislative levels. Although CBD and its derivatives are currently Schedule 1 substances per the federal Controlled Substances Act (CSA), many states have relaxed their legislation to allow use. More recently, the use of cannabidiol (CBD) products in pediatrics has sparked additional debate, and pediatric providers have started encountering patients experimenting with these products in their daily practice, necessitating an understanding of the history and available medical literature on this CBD related topic.

Many of the misconceptions regarding full spectrum CBD oil in the pediatric population stem from negative connotations associated with the term marijuana owing to its psychoactive effects. Therefore, it is important to define the various terms associated with CBD products that are currently being used by the public as well as by pediatric researchers. Cannabis is a general term that refers to the 3 species of hemp plants (Cannabis sativaCannabis indicaCannabis ruderalis). Marijuana is a term that describes the dried leaves, flowers, stems, and seeds from the hemp plant that are often smoked for recreational and medicinal use. CBD contains various different chemicals called cannabinoids. Cannabinoids are the chemicals found within cannabis that interact with specific receptors, namely, cannabinoid (CB) receptors, within the body. The over 60 types of cannabinoids currently identified differ by the degree to which they are psychoactive. While delta-9-tetrahydrocannabinol (THC), the cannabinoid most commonly associated with marijuana as a drug of abuse, is psychoactive, other cannabinoids including CBD are not. THC has been linked to the development of schizophrenia, and a contributor to neurodevelopment deficits in adolescents., Different CBD strains will have varying amounts of both THC and CBD, and thus the concentrations and ratios of these different cannabinoids within a product, especially for pediatric use, has been a subject of interest not only for medical professionals but also for state legislators as well.

Oxycodone Detox Center

Research included a patient who had abruptly ceased injecting heroin to stop abuse and self-managed opioid withdrawal and chronic pain using kratom. After co-administering the herb with maltodextrin he experienced a multi virtual seizure, but he reported only modest abstinence once kratom administration stopped. Researchers confirmed the identity of the plant matter he ingested as kratom and identified no contaminant substance or adulterants. The study showed no conclusion of high-throughput molecular screening and the binding affinity at mu, delta and kappa receptors of mitragynine.

The university reported the self-treatment of chronic pain and opioid withdrawal with kratom. The predominantly accepted dosage of kratom capsules,  containing mitragynine, binds mu- and kappa-opioid receptors, but has additional receptor modules that might augment its effectiveness at mitigating opiate withdrawal. The natural geographical history of kratom use, including its clinical pharmacology and toxicology, are increasingly understood.

Sales of the nation’s two most popular prescription painkillers have exploded in new parts of the country, an Associated Press analysis shows, worrying experts who say the push to relieve patients’ suffering is spawning an addiction epidemic.

In 2015, more people died of a drug overdose than in any other year on record, and most of these overdose related  deaths involved an prescription pain killers. Opioid-related deaths have quadrupled from 1998 to 2013, with an apparent disconnect between pain and the prescription of oxycodone: During this time period, the amount of oxycontin prescribed nearly quadrupled; however, hospital patients’ overall pain ratings remained the same. Given the abundance of prescription opioids being written by doctors- causing abuse problems, national protests and attention has overwhelmingly focused on the appropriate prescribing of oxycontin, as well as patient and prescriber education. The DEA recently established guidelines for prescribing opioids for chronic pain, and all healthcare nurse practitioners should be familiar with these guidelines in order to avoid inadvertently fostering abuse.

Among acute opioid-abuse issues, heroin overdose is readily discussed; however, the problem of acute withdrawal symptoms associated with opioid-detoxification syndrome, especially in the acute-care treatment setting, deserves equal attention. Treatment of oxycontin withdrawal depends on the healthcare setting, the type(s) of substances abused, and individual patient characteristics.

Medical professionals have long been on high alert about powerful painkillers like OxyContin because of their widespread abuse by teenagers and others for recreational purposes. These opioid medications require a patient to attend residential oxycontin detox programs.